StockData
Medicenna Therapeutics Corp. logo

Medicenna Therapeutics Corp. (MDNAF) stock

MDNAFOTCPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới năm tài chính 2023, năm kết thúc ngày Mar 31, 2023Last filing: 20-F on Jun 27, 2023
$0.28−0.02 (-7.63%)

Close on Oct 19, 2026

Medicenna Therapeutics cash

Cash and short-term investments held at the end of each period.

Medicenna Therapeutics's cash was C$33.60M at Mar 31, 2023. For fiscal 2023 it was C$33.60M, up 63.6% from the year before. The highest annual figure on record is C$33.60M in fiscal 2023.

Annual cash

PeriodPeriod endValueChange
FY2023Mar 31, 2023C$33.60M+63.6%
FY2022Mar 31, 2022C$20.54M-32.4%
FY2021Mar 31, 2021C$30.38M+33.8%
FY2020Mar 31, 2020C$22.70M+857.3%
FY2019Mar 31, 2019C$2.37M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2023CQ1 2023Mar 31, 2023C$33.60M+10.6%
Q3 FY2023CQ4 2022Dec 31, 2022C$20.54M-9.5%
Q4 FY2022CQ1 2022Mar 31, 2022C$20.54M-9.5%
Q3 FY2022CQ4 2021Dec 31, 2021C$30.38M+1181.1%
Q4 FY2021CQ1 2021Mar 31, 2021C$30.38M–
Q3 FY2021CQ4 2020Dec 31, 2020C$22.70M–
Q4 FY2020CQ1 2020Mar 31, 2020C$22.70M–
Q4 FY2019CQ1 2019Mar 31, 2019C$2.37M–

More Medicenna Therapeutics figures

See a number that looks wrong?